Cabot (NYSE:CBT) Earns Buy Rating from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Cabot (NYSE:CBT – Get Rating) in a research note issued on Thursday. The firm set a “buy” rating on the specialty chemicals company’s stock.

Other equities research analysts also recently issued reports about the stock. Loop Capital lifted their price target on shares of Cabot from $98.00 to $113.00 and gave the company a “buy” rating in a research report on Monday, February 13th. Credit Suisse Group assumed coverage on shares of Cabot in a research note on Monday. They issued an “outperform” rating and a $94.00 price objective on the stock. JPMorgan Chase & Co. upped their price target on shares of Cabot from $80.00 to $87.00 and gave the company an “overweight” rating in a research report on Monday, February 13th. Finally, Deutsche Bank Aktiengesellschaft raised Cabot from a “hold” rating to a “buy” rating and boosted their target price for the company from $80.00 to $90.00 in a research report on Wednesday, November 16th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Cabot has a consensus rating of “Buy” and a consensus price target of $96.00.

Cabot Stock Down 4.2 %

Shares of CBT opened at $72.61 on Thursday. The firm has a market capitalization of $4.09 billion, a price-to-earnings ratio of 11.90 and a beta of 1.36. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.11 and a current ratio of 1.83. The business’s fifty day moving average price is $75.41 and its two-hundred day moving average price is $71.75. Cabot has a 52 week low of $59.65 and a 52 week high of $83.74.

Cabot (NYSE:CBT – Get Rating) last released its quarterly earnings results on Friday, February 10th. The specialty chemicals company reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.02. The firm had revenue of $965.00 million for the quarter, compared to the consensus estimate of $955.24 million. Cabot had a return on equity of 32.03% and a net margin of 8.15%. The company’s revenue for the quarter was down .3% on a year-over-year basis. During the same quarter last year, the business posted $1.29 EPS. On average, analysts predict that Cabot will post 6.41 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. increased its stake in shares of Cabot by 11.0% in the first quarter. BlackRock Inc. now owns 6,931,530 shares of the specialty chemicals company’s stock worth $474,186,000 after purchasing an additional 686,769 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Cabot by 237.4% during the 2nd quarter. Goldman Sachs Group Inc. now owns 600,154 shares of the specialty chemicals company’s stock valued at $38,284,000 after buying an additional 422,273 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Cabot by 6.5% during the 1st quarter. Vanguard Group Inc. now owns 6,120,453 shares of the specialty chemicals company’s stock valued at $418,701,000 after buying an additional 374,834 shares in the last quarter. Wellington Management Group LLP increased its position in Cabot by 11.1% during the 1st quarter. Wellington Management Group LLP now owns 3,541,491 shares of the specialty chemicals company’s stock valued at $242,273,000 after purchasing an additional 353,154 shares during the period. Finally, Invesco Ltd. grew its position in shares of Cabot by 272.1% in the 1st quarter. Invesco Ltd. now owns 453,292 shares of the specialty chemicals company’s stock worth $31,010,000 after buying an additional 331,479 shares during the last quarter. 94.21% of the stock is currently owned by institutional investors.

Cabot Company Profile

(Get Rating)

Cabot Corp. is a global specialty chemicals and performance materials company. Its products are rubber and specialty grade carbon blacks, specialty compounds, fumed metal oxides, activated carbons, inkjet colorants, and aerogel. The company operates through the following segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions.